1. Home
  2. CHEK vs NBY Comparison

CHEK vs NBY Comparison

Compare CHEK & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • NBY
  • Stock Information
  • Founded
  • CHEK 2004
  • NBY 2000
  • Country
  • CHEK Israel
  • NBY United States
  • Employees
  • CHEK 85
  • NBY N/A
  • Industry
  • CHEK Medical Electronics
  • NBY
  • Sector
  • CHEK Health Care
  • NBY
  • Exchange
  • CHEK Nasdaq
  • NBY Nasdaq
  • Market Cap
  • CHEK 4.8M
  • NBY 3.4M
  • IPO Year
  • CHEK 2015
  • NBY 2007
  • Fundamental
  • Price
  • CHEK $0.80
  • NBY $0.58
  • Analyst Decision
  • CHEK
  • NBY Strong Buy
  • Analyst Count
  • CHEK 0
  • NBY 1
  • Target Price
  • CHEK N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • CHEK 125.3K
  • NBY 41.7K
  • Earning Date
  • CHEK 06-17-2025
  • NBY 05-15-2025
  • Dividend Yield
  • CHEK N/A
  • NBY N/A
  • EPS Growth
  • CHEK N/A
  • NBY N/A
  • EPS
  • CHEK N/A
  • NBY 0.57
  • Revenue
  • CHEK N/A
  • NBY $9,781,000.00
  • Revenue This Year
  • CHEK N/A
  • NBY $23.91
  • Revenue Next Year
  • CHEK N/A
  • NBY $32.05
  • P/E Ratio
  • CHEK N/A
  • NBY $1.27
  • Revenue Growth
  • CHEK N/A
  • NBY 20.52
  • 52 Week Low
  • CHEK $0.56
  • NBY $0.36
  • 52 Week High
  • CHEK $3.04
  • NBY $3.15
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 46.52
  • NBY 52.01
  • Support Level
  • CHEK $0.78
  • NBY $0.55
  • Resistance Level
  • CHEK $0.86
  • NBY $0.61
  • Average True Range (ATR)
  • CHEK 0.04
  • NBY 0.02
  • MACD
  • CHEK -0.01
  • NBY 0.00
  • Stochastic Oscillator
  • CHEK 15.73
  • NBY 50.00

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: